No Data
No Data
Ainos Enrolls First Subject For Clinical Study Of VELDONA-Based Animal FCGS Drug; Dosing Of The First Subject Is Expected To Occur On July 26, 2024.
12 Health Care Stocks Moving In Thursday's Intraday Session
Market Mover | Ainos Shares Soar 30% After the Company Reports Progress in Clinical Trials of Ainos Flora Testing Device
Ainos AIMD AI Ainos Flora Leverage; Bio-Path BPTH Phase 2 Data
Express News | Ainos Inc - Clinical Trials for AI Nose-Powered Ainos Flora Device Moves Forward With 75Meaningful Case Results
Express News | Ainos Inc - Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by Nvidia Cuda
No Data
carlton griffiths OP : correction 0.85